William A Schumacher Selected Research

Cerebrovascular Disorders (Cerebrovascular Occlusion)

1/2017

Blockade of protease-activated receptor-4 (PAR4) provides robust antithrombotic activity with low bleeding.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

William A Schumacher Research Topics

Disease

17	Thrombosis (Thrombus) 02/2024 - 01/2007
13	Hemorrhage 02/2024 - 01/2007
5	Venous Thrombosis (Deep-Vein Thrombosis) 08/2012 - 01/2002
3	Heart Failure 12/2021 - 01/2021
3	Carotid Artery Thrombosis 01/2009 - 05/2007
3	Weight Loss (Weight Reduction) 01/2009 - 05/2007
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2021
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2017
1	Inflammation (Inflammations) 01/2007
1	Vascular System Injuries 01/2007
1	Brain Injuries (Brain Injury) 04/2004
1	Ischemia 04/2004
1	Ischemic Stroke 04/2004
1	Brain Ischemia (Cerebral Ischemia) 04/2004
1	Neuroinflammatory Diseases 04/2004
1	Asthma (Bronchial Asthma) 11/2002

Drug/Important Bio-Agent (IBA)

6	Clopidogrel (Plavix)FDA Link 01/2017 - 05/2007
5	Thrombin FDA Link 02/2024 - 01/2002
3	ferric chlorideIBA 08/2012 - 02/2007
3	Thromboplastin (Tissue Factor)IBA 06/2010 - 01/2007
2	Apelin ReceptorsIBA 11/2021 - 01/2021
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2017 - 11/2013
2	Peptide Hydrolases (Proteases)FDA Link 01/2017 - 03/2010
2	BMS-262084IBA 08/2011 - 09/2007
2	Blood Coagulation Factors (Coagulation Factor)IBA 03/2010 - 09/2007
2	Adenosine Diphosphate (ADP)IBA 01/2009 - 07/2007
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2008 - 07/2007
2	CarboxypeptidasesIBA 02/2007 - 01/2007
1	QuinoxalinesIBA 02/2024
1	protease-activated receptor 4IBA 02/2024
1	compound 21IBA 12/2021
1	apelin-13 peptideIBA 01/2021
1	AntibodiesIBA 01/2017
1	BMS-986120IBA 01/2017
1	CD100 antigenIBA 06/2013
1	2- iodo- N(6)- methyl- (N)- methanocarba- 2'- deoxyadenosine- 3',5'- bisphosphateIBA 08/2012
1	Purinergic P2Y1 ReceptorsIBA 08/2012
1	PrekallikreinIBA 06/2012
1	Plasma KallikreinIBA 06/2012
1	Phosphatidylinositols (Phosphatidylinositol)IBA 06/2011
1	TGX 221IBA 06/2011
1	Heparin (Liquaemin)FDA LinkGeneric 06/2010
1	Factor Xa InhibitorsIBA 06/2010
1	apixabanIBA 06/2010
1	AnticoagulantsIBA 03/2010
1	ThienopyridinesIBA 01/2009
1	Prasugrel Hydrochloride FDA Link 01/2009
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2008
1	Tirofiban (Aggrastat)FDA Link 01/2008
1	argatroban (MPQA)FDA Link 01/2008
1	CoagulantsIBA 01/2008
1	HirudinsIBA 01/2008
1	Factor XIa (Coagulation Factor XIa)IBA 09/2007
1	Dihydrotachysterol (AT 10)IBA 07/2007
1	vasodilator-stimulated phosphoproteinIBA 07/2007
1	Biomarkers (Surrogate Marker)IBA 07/2007
1	FibrinIBA 02/2007
1	Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA 02/2007
1	Messenger RNA (mRNA)IBA 01/2007
1	ribosomal protein L32IBA 01/2007
1	P-SelectinIBA 01/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2004
1	CytokinesIBA 04/2004
1	ADAM17 ProteinIBA 04/2004
1	DPH-067517IBA 04/2004
1	Serine Proteases (Serine Protease)IBA 11/2002
1	Tryptases (Tryptase)IBA 11/2002
1	BMS 189090IBA 01/2002
1	BMS 189664IBA 01/2002

Therapy/Procedure

3	Therapeutics 02/2024 - 03/2010
1	Nephrotomy 01/2007